Why Afya Limited’s (AFYA) Stock Is Down 5.03%
As of Wednesday, October 28, Afya Limited’s AFYA share price has dipped by 5.03%, which has investors questioning if this is right time to buy.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions. The Undergraduate segment offers educational services through undergraduate courses related to medical school, health sciences, and other non-health undergraduate programs, including medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, biomedicine, business administration, accounting, law, civil and industrial engineering, and pedagogy. The Continuing Education segment provides medical education, including residency preparation programs, specialization test preparation, graduate courses in medicine, and digital and in-person professional development for physicians and medical students. The Medical Practice Solutions segment offers clinical decision support platforms, medical practice management software, healthcare financial services, and digital healthcare ecosystem solutions, such as electronic medical records, practice management tools, telemedicine, digital prescriptions, and doctor-patient relationship platforms. This segment also provides a subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. The company also offers educational health and medical imaging; and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. In addition, it offers printed and digital content, as well as an online medical education platform and physicians, healthcare professionals and students. Afya Limited was founded in 1999 and is headquartered in Belo Horizonte, Brazil.
Commentary & Analysis
Why Afya Limited’s (AFYA) Stock Is Down 17.83%
As of Monday, October 26, Afya Limited’s AFYA share price has dipped by 17.83%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Afya Limited’s (AFYA) Stock Is Down 31.35%
As of Monday, October 26, Afya Limited’s AFYA share price has dipped by 31.35%, which has investors questioning if this is right time to buy.Omar Beirat
3 Undervalued Diversified Consumer Services Stocks for Monday, October 19
Discover the top 3 undervalued Diversified Consumer Services stocks for Monday, October 19 based on AAII’s Stock Grades.Rosalio Madrigal
Why Afya Limited’s (AFYA) Stock Is Up 6.46%
As of Monday, October 05, Afya Limited’s AFYA share price has surged by 6.46%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | AFYA | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $899.8 | $75.3 | 45% |
|
| Shares Out (Mil) | 17.2 | 17.5 | 28% |
|
| Institutional Ownership | 48.3% | 57.9% | 22% |
|
| Float (Mil) | na | 11.9 | na |
|
| Beta | 0.38 | 0.97 | 22% |
|
| Avg Daily Volume (000s) | 554 | 198 | 60% |
|
| Price Change (52-week) |
(29.8%) | 46.7% | 30% |
|
| Growth | AFYA | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 23.8% | 5.7% | 85% |
|
| Net Income (5yr) | 19.4% | 15.5% | 72% |
|
| EPS (5yr) | 20.0% | 15.8% | 68 |
|
| Dividends (5yr) | 0.0% | 0.0% | 73% |
|
| Cash Flow (5yr) | 16.6% | (15.5%) | 75% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 4 | 5 | 6 | |
| Current EPS | $0.374 | $1.709 | $1.872 | |
| Month Ago EPS | $0.343 | $1.708 | $1.888 | |
| # Rev Up | 0 | 2 | 1 | |
| # Rev Down | 1 | 0 | 0 | |
| Three Months Ago EPS | $0.372 | $1.719 | $1.887 | |
| Year/Year Chg | (12.4%) | 14.2% | 33.8% | |
| Financials | AFYA | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $739 | $245 | 46% |
|
| Net Income (TTM) (Mil) | $151 | $2 | 65% |
|
| EPS (TTM) | $1.681 | $0.000 | 68% |
|
| Operating Cash Flow (TTM) (Mil) | $301 | $4 | 64% |
|
| Net Cash Flow (TTM) (Mil) | ($19) | $1 | 27% |
|
| Long-Term Debt (Q1) (Mil) | $566 | $16 | 60% |
|
| Enterprise Value (Q1) (Mil) | $1,598 | $149 | 46% |
|
| Valuation | AFYA | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.95 | 1.71 | 23% |
|
| P/E | 6.1 | 13.0 | 6% |
|
| Dividend Yield | 33.9% | 0.0% | 100% |
|
| PEG (5yr hist) | 0.3 | 0.6 | 14% |
|
| Ratios | AFYA | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 64.0% | 45.9% | 76% |
|
| Net Margin | 20.4% | 2.7% | 79% |
|
| ROA | 8.6% | 0.6% | 84% |
|
| ROE | 16.9% | 6.6% | 74% |
|
| Liabilities to Assets | 47.2% | 48.9% | 39% |
|
| F-Score | 6 | 4 | 68% |
|
Passing Stock Screens
As of 10/29/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Buffettology: EPS Growth
Factors: Quality, Growth
Buffett approach seeking consumer monopolies selling at a reasonable price.
| Performance Since Inception: | 12.2% |
| +/- S&P 500: | +4.7 |
GURU STRATEGY
Lynch Screen
Factors: Value
A strictly bottom-up approach, focusing on companies familiar to the investor.
| Performance Since Inception: | 9.9% |
| +/- S&P 500: | +2.4 |
GURU STRATEGY
Muhlenkamp Screen
Factors: Value, Quality, Growth
Muhlenkamp uses a bottom-up approach to selecting stocks, but adjusts his benchmarks based upon the broad economic environment.
| Performance Since Inception: | 6.0% |
| +/- S&P 500: | -1.5 |
FACTOR STRATEGY
Price-to-Free-Cash-Flow Screen
Factors: Value
An exploration of the basics of cash flow analysis and the implementation of a price-to-free-cash-flow screen.
| Performance Since Inception: | 16.3% |
| +/- S&P 500: | +8.8 |
FACTOR STRATEGY
Price-to-Sales Screen
Factors: Value, Growth
Research indicates that using price-to-sales ratios may lead to better investment results than price-to-book-value ratios or price-earnings ratios.
| Performance Since Inception: | 13.0% |
| +/- S&P 500: | +5.5 |
GURU STRATEGY
Rule #1 Investing Screen
Factors: Value, Quality, Growth
Adapted from Phil Town's Rule #1 book, this screen attempts to identify wonderful companies with attractive prices.
| Performance Since Inception: | 8.3% |
| +/- S&P 500: | +0.8 |
GURU STRATEGY
Wanger Screen
Factors: Value, Size, Growth
First introduced in May 1997, this approach focuses on limiting the risks of investing in small-cap stocks.
| Performance Since Inception: | 12.2% |
| +/- S&P 500: | +4.7 |
GURU STRATEGY
Buffettology: Sustainable Growth Screen
Factors: Quality, Growth
Buffett approach seeking consumer monopolies selling at a reasonable price.
| Performance Since Inception: | 13.0% |
| +/- S&P 500: | +5.5 |
